Overview and Development of the Child Health and Mortality Prevention Surveillance Determination of Cause of Death (DeCoDe) Process and DeCoDe Diagnosis Standards.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
09 10 2019
Historique:
received: 16 04 2019
accepted: 18 07 2019
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 8 9 2020
Statut: ppublish

Résumé

Mortality surveillance and cause of death data are instrumental in improving health, identifying diseases and conditions that cause a high burden of preventable deaths, and allocating resources to prevent these deaths. The Child Health and Mortality Prevention Surveillance (CHAMPS) network uses a standardized process to define, assign, and code causes of stillbirth and child death (<5 years of age) across the CHAMPS network. A Determination of Cause of Death (DeCoDe) panel composed of experts from a local CHAMPS site analyzes all available individual information, including laboratory, histopathology, abstracted clinical records, and verbal autopsy findings for each case and, if applicable, also for the mother. Using this information, the site panel ascertains the underlying cause (event that precipitated the fatal sequence of events) and other antecedent, immediate, and maternal causes of death in accordance with the International Classification of Diseases, Tenth Revision and the World Health Organization death certificate. Development and use of the CHAMPS diagnosis standards-a framework of required evidence to support cause of death determination-assures a homogenized procedure leading to a more consistent interpretation of complex data across the CHAMPS network. This and other standardizations ensures future comparability with other sources of mortality data produced externally to this project. Early lessons learned from implementation of DeCoDe in 5 CHAMPS sites in sub-Saharan Africa and Bangladesh have been incorporated into the DeCoDe process, and the implementation of DeCoDe has the potential to spur health systems improvements and local public health action.

Identifiants

pubmed: 31598661
pii: 5584383
doi: 10.1093/cid/ciz572
pmc: PMC6785670
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S333-S341

Subventions

Organisme : Wellcome Trust
ID : 205184/Z/16/Z
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Lancet. 2014 Sep 6;384(9946):894-903
pubmed: 25209489
Popul Health Metr. 2011 Aug 04;9:27
pubmed: 21816095
BMC Med. 2014 Feb 04;12:19
pubmed: 24495839
Vaccine. 2016 Dec 1;34(49):6015-6026
pubmed: 27435386
S Afr Med J. 2016 Aug 08;106(9):851-2
pubmed: 27601103
Lancet. 2007 Nov 3;370(9598):1569-77
pubmed: 17992727
Pediatrics. 2012 Feb;129(2):e486-93
pubmed: 22232303
Lancet. 2014 Sep 6;384(9946):904-14
pubmed: 25209490
Lancet. 2015 Oct 3;386(10001):1395-1406
pubmed: 25971218
Lancet. 2014 Sep 6;384(9946):915-27
pubmed: 25209491
PLoS Med. 2009 Feb 24;6(2):e1000036
pubmed: 19243215

Auteurs

Dianna M Blau (DM)

Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

J Patrick Caneer (JP)

Public Health Informatics Institute, The Task Force for Global Health, Atlanta, Georgia, USA.

Rebecca P Philipsborn (RP)

Emory Global Health Institute, Emory University, Atlanta, Georgia, USA.

Shabir A Madhi (SA)

Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.

Quique Bassat (Q)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.
Consorcio de Investigacion Biomedica en Red de Epidemiologia y Salud, Spain.

Rosauro Varo (R)

ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.

Inácio Mandomando (I)

Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Instituto Nacional de Saude, Ministerio de Saude, Maputo, Mozambique.

Kitiezo Aggrey Igunza (KA)

Kenya Medical Research Unit, Kenya Medical Research Institute (KEMRI), Kisusmu, Kenya.

Karen L Kotloff (KL)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Milagritos D Tapia (MD)

Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Siobhan Johnstone (S)

Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.

Richard Chawana (R)

Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Department of Science and Technology/National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.

Afruna Rahman (A)

PEI, Infectious Disease Division, icddr,b, Dhaka, Bangladesh.

Shams El Arifeen (S)

Maternal and Child Health Division, icddr,b, Dhaka, Bangladesh.

Dickens Onyango (D)

Kisumu County Department of Health, Kisumu, Kenya.

Reinhard Kaiser (R)

US Centers for Disease Control and Prevention--Sierra Leone, Freetown, Sierra Leone.

Anna C Seale (AC)

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.

Nega Assefa (N)

College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.

Timothy Morris (T)

Public Health Informatics Institute, The Task Force for Global Health, Atlanta, Georgia, USA.

Pratima L Raghunathan (PL)

Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Robert F Breiman (RF)

Emory Global Health Institute, Emory University, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH